Jared Kaltwasser

The launch is one of several digital therapeutics partnerships Pfizer has announced in recent months.

The guide is designed to help spread best practices and help healthcare decision-makers understand the benefits of digital therapeutics.

Data suggest most patients have positive serology results a month following vaccination with either the Moderna or Pfizer vaccine.

The frequency of rapid eye movement appears to be associated with several psychiatric and neurological disorders, investigators said.

Using a data set of more than 100,000 people, investigators found getting more than seven hours of sleep per night reduced the risk of developing fatty liver disease.

It is not clear whether gut inflammation has a causal role in myeloproliferative neoplasms, or the other way around.

Data suggest a smartphone application can boost physical activity and relieve symptoms of chronic obstructive pulmonary disease.

High engagement was linked with high weight loss, the analysis shows.

An integrated approach not only leads to better results, but also better value, in both the short- and long-term, according to DarioHealth.

Patients with lower heart rate variability during sleep may suffer from insomnia, the study found.

It is not yet clear whether Alzheimer’s causes excessive napping or vice versa, but the study’s authors say the questions are worthy of additional investigation.

Patients with obstructive sleep apnea who used continuous positive airway pressure devices were able to slow down their epigenetic age acceleration.

Humans still have a role, but in a recent survey, about half of insurers said they are using AI to help cut down on fraud, waste and abuse.

The digital therapeutic is being marketed as an alternative to specialist-guided therapy or at-home exercises.

The company says the therapeutic will fill an unmet need with a 12-week course of therapy for irritable bowel syndrome.

A company-sponsored study found that Theranica’s digital therapeutic Nerivio resulted in a substantial reduction in intake of prescribed pharmacological medications

Voluntary guidelines passed in January show a way to making interoperability work on a practical level.

Children with poor sleep had a 2.6-fold higher risk of developing adult insomnia, according to longitudinal research conducted by Penn State researchers.

Preliminary research using an animal model found that hypoxia during pregnancy had behavioral and neuropsychiatric impacts on offspring.

A new study sheds light on the nature of the “long covid.” Researchers say SARS-CoV-2 needs to be viewed not as a respiratory virus but as one with systematic effects.

Adoption of digital health technologies came fast and furious in the pandemic, but now it’s up to insurers and patients to figure out the best recipe for a mix of remote and in-person care.

The questionnaire is seen as a low-risk, high-reward method of assessing asthma comorbidities in children.

Most of the studies into socioeconomic status and obstructive sleep apnea have limitations that make causal inference difficult.

Though blockchain remains very much a work in progress for health insurers, one of the industry’s first significant forays into the technology is yielding promising early returns.

Advantages may run into entrenched interests.

The model could make it quicker and easier to decide whether patients need continuous positive airflow pressure machines or not.

A new model of the hypothalamus can lead to potential new genetic targets for a number of disorders.

A new study suggests clinicians might be able to use metabolic “fingerprints” to better understand the likely severity of individual cases.

A new report suggests infants who do not get enough sleep can quickly become overweight.

The Pfizer and Moderna COVID-19 vaccines introduced much of the world to ribonucleic acid (RNA), which has long played second fiddle to DNA. But in addition to the messenger RNA vaccines, treatments targeting and using RNA in a variety of ways are filling the pipeline and exciting researchers and drug developers.